Back

Dexrazoxane and liposomal anthracyclines

20 June 2025 (15:20 - 15:35)
Organised by: Logo
Congress Presentation Part of: Optimising cardioprotection in patients with cancer Secondary Prevention CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Doctor Ariane Macedo

Santa Casa de Misericórdia de Sao Paulo, Sao Paulo (Brazil)

3 More presentations in this session

Presentation thumbnail
Integrating renin-angiotensin inhibitors, beta-blockers, and ARNIs
Doctor C. Plummer (Newcastle Upon Tyne, GB)
Slides Video
Presentation thumbnail
The role of statins and SGLT2 inhibitors
Doctor M. Scherrer-Crosbie (Philadelphia, US)
Slides Video
Presentation thumbnail
Optimising cardioprotection in cancer patients - discussion
Video

Access the full session

Session thumbnail
Optimising cardioprotection in patients with cancer

The Event

Event poster

ESC Cardio-Oncology 2025

20 June 2025 15:20 CET
You may be interested in
thumbnail
Congress Presentation
Why, when, and how to prevent cardiotoxicity? gaps in knowledge
20 June 2025
thumbnail
Congress Presentation
New strategies to protect against anthracycline cardiotoxicity
21 June 2025
thumbnail
Congress Presentation
Principles of cancer therapy for solid tumours
20 June 2025
thumbnail
Congress Presentation
Can my patient with heart failure get anthracycline therapy?
10 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources